Peter Kozuch, MD, discusses the phase 2/3 CIRCULATE-US trial evaluating chemotherapy decisions for patients with resected colorectal cancer based on circulating tumor DNA status.
Peter Kozuch, MD
Advertisement
Articles by Peter Kozuch, MD
Peter Kozuch, MD, discusses the role of circulating tumor DNA in colorectal cancer.
Advertisement
Latest Updated Articles
Dr. Kozuch on the Evaluation of ctDNA in the CIRCULATE-US Trial in Resected CRCPublished: January 10th 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5